Literature DB >> 9707418

The clathrin endocytic pathway in viral infection.

L DeTulleo1, T Kirchhausen.   

Abstract

How important is the clathrin-dependent endocytic pathway for entry of viruses into host cells? While it is widely accepted that Semliki Forest virus (SFV), an enveloped virus, requires this pathway there are conflicting data concerning the closely related Sindbis virus, as well as varying results with picornaviruses such as human rhinovirus 14 (HRV 14) and poliovirus. We have examined the entry mode of SFV, Sindbis virus, HRV 14 and poliovirus using a method that identifies single infected cells. This assay takes advantage of the observation that the clathrin-dependent endocytic pathway is specifically and potently arrested by overexpression of dynamin mutants that prevent clathrin-coated pit budding. Using HeLa cells and conditions of low multiplicity of infection to favor use of the most avid pathway of cell entry, it was found that SFV, Sindbis virus and HRV 14 require an active clathrin-dependent endocytic pathway for successful infection. In marked contrast, infection of HeLa cells by poliovirus did not appear to require the clathrin pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707418      PMCID: PMC1170788          DOI: 10.1093/emboj/17.16.4585

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  Effects of monovalent cations on Semliki Forest virus entry into BHK-21 cells.

Authors:  A Helenius; M Kielian; J Wellsteed; I Mellman; G Rudnick
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

2.  Inhibition of endocytosis by anti-clathrin antibodies.

Authors:  S J Doxsey; F M Brodsky; G S Blank; A Helenius
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

3.  Semliki forest virus entry and the endocytic pathway.

Authors:  M Marsh; M C Kielian; A Helenius
Journal:  Biochem Soc Trans       Date:  1984-12       Impact factor: 5.407

4.  Effect of reduced endocytosis induced by hypotonic shock and potassium depletion on the infection of Hep 2 cells by picornaviruses.

Authors:  I H Madshus; K Sandvig; S Olsnes; B van Deurs
Journal:  J Cell Physiol       Date:  1987-04       Impact factor: 6.384

5.  Recovery of structurally intact and infectious poliovirus type 1 from HeLa cells during receptor-mediated endocytosis.

Authors:  P Willingmann; H Barnert; H Zeichhardt; K O Habermehl
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

6.  The major human rhinovirus receptor is ICAM-1.

Authors:  J M Greve; G Davis; A M Meyer; C P Forte; S C Yost; C W Marlor; M E Kamarck; A McClelland
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

7.  A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses.

Authors:  D E Staunton; V J Merluzzi; R Rothlein; R Barton; S D Marlin; T A Springer
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1.

Authors:  J E Tomassini; D Graham; C M DeWitt; D W Lineberger; J A Rodkey; R J Colonno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus.

Authors:  S Cassell; J Edwards; D T Brown
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

10.  Requirements for entry of poliovirus RNA into cells at low pH.

Authors:  I H Madshus; S Olsnes; K Sandvig
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  112 in total

1.  Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes.

Authors:  J M Smit; R Bittman; J Wilschut
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Distinct cellular receptor interactions in poliovirus and rhinoviruses.

Authors:  L Xing; K Tjarnlund; B Lindqvist; G G Kaplan; D Feigelstock; R H Cheng; J M Casasnovas
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

3.  Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus.

Authors:  D M Belnap; D J Filman; B L Trus; N Cheng; F P Booy; J F Conway; S Curry; C N Hiremath; S K Tsang; A C Steven; J M Hogle
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

Authors:  S B Deitz; D A Dodd; S Cooper; P Parham; K Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  PE2 cleavage mutants of Sindbis virus: correlation between viral infectivity and pH-dependent membrane fusion activation of the spike heterodimer.

Authors:  J M Smit; W B Klimstra; K D Ryman; R Bittman; R E Johnston; J Wilschut
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  The interaction of alphavirus E1 protein with exogenous domain III defines stages in virus-membrane fusion.

Authors:  Gleyder Roman-Sosa; Margaret Kielian
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 7.  Poliovirus cell entry: common structural themes in viral cell entry pathways.

Authors:  James M Hogle
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

8.  Receptor priming of major group human rhinoviruses for uncoating and entry at mild low-pH environments.

Authors:  Ghasem Nurani; Birgitta Lindqvist; José M Casasnovas
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Assembly of endocytic machinery around individual influenza viruses during viral entry.

Authors:  Michael J Rust; Melike Lakadamyali; Feng Zhang; Xiaowei Zhuang
Journal:  Nat Struct Mol Biol       Date:  2004-05-02       Impact factor: 15.369

10.  Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin.

Authors:  Jolanda M Smit; Barry-Lee Waarts; Koji Kimata; William B Klimstra; Robert Bittman; Jan Wilschut
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.